FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

New MS collaboration unveiled at Edmonton Kaye Clinic

Brienne McKenzie (left), Phd student, and Manmeet Mamik, post-doctoral student, work in the Brain Power Lab at the University of Alberta in Edmonton, Alta., on Thursday March 10, 2016. Alberta Economic Development and Trade and Sanofi Genzyme Canada are contributing $500,000 each towards multiple sclerosis research through the Alberta Multiple Sclerosis Collaboration. Photo by Ian Kucerak

The province has found their first industry partner to help contribute $1 million towards advancing research and improving care for Albertans suffering from multiple sclerosis.

On Thursday, Alberta’s associate health minister, Brandy Payne, announced the government will contribute $500,000 to Campus Alberta Neuroscience (CAN), a province-wide network of 250 researchers working in neuroscience and mental health, as part of the Alberta Multiple Sclerosis Collaboration initiative, which was originally formed in 2014 by CAN and the Alberta MS Network.

“Thanks to this innovative partnership, people with MS in Alberta and around the world will benefit from improved care and better health solutions,” Payne said while speaking to a crowd at Edmonton’s Kaye Clinic.

As the first industry partner in the MS Collaboration, global biotechnology company Sanofi Genzyme Canada announced they will be matching the government’s contribution to top off the $1-million fund.

“Sanofi Genzyme recognizes that collaboration is essential to accelerate and facilitate research and health innovation. We are a proud partner in this venture that will ultimately improve the health of people living with MS,” said Sanofi Genzyme Canada general manager, Peter Brenders.

The province hopes the announcement will help attract other industry partners to contribute to the fund in the future.

Alberta is said to have one of the highest rates of MS in the world. In Canada, there are 240 cases of MS for every 100,000 Canadians, but that number is higher in Alberta with about 340 out of every 100,000 Albertans diagnosed with MS.

“While Alberta is known as the MS capital of the world, Alberta also has some of the best MS researchers,” said Alberta MS Network director Dr. V. Wee Yong.

Story Source: The above story is based on materials provided by CANADA.COM
Note: Materials may be edited for content and length



Go to Newer News Go to Older News